Outcome of Board Meeting dated November 06, 2026.

AA IEEHIE .=~ INTERCONTINENTAL LTD. CIN.12 4100GJ1984PLC111413 Reg. Office: 1-5th Floor, Aditraj Arcade, Nr Karma Shreshtha Tower, 100 Ft Rd, Satellite, Ahmedabad - 380015. Date: 6t November, 2026 Listing Compliances, Listing Compliances, BSE Limited, CSE - India, P.J. Towers, 7, Lyons Range, Dalhousie Fort, Mumbai - 400001. Kolk- 7a00t00a1. Scrip Code: 539938; Scrip Id: MIL Subject: Outcome of Board Meeting and Compliances of Regulation 30 and 33 of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015. Dear Sir/Ma’am, Pursuant to provisions of Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board ofD irectors of the Company at its meeting held today i.e, November 06, 2026, inter alia, considered and approved Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended on September 30, 2026 along with Limited review report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. Further, please find enclosed “Standalone and Consolidated unaudited Financial Results along with Limited Review Report” for the quarter and half year ended on September 30, 2026 as Annexure 1 and same is also available on the website of the Company viz. www.medicointercontinental.com The Board Meeting of the Company commenced at 01:00 PM and concluded at 01:30 PM. This is for your information and records. Thanking You, FORMEDICO INTERCONTINENTAL LIMITED Digitally signed SAMIR by SAMIR DILIPKUM JLPKomar AR SHAH Date: 2026.11.06 13:32:23 +05'30" Samir D Shah Managing Director (DIN: 03350268) Godown Address: 12 & 19/1a, Madhav Estate, Near IBP Petrol pump, Forest Section-1, Aslali, Ahmedabad-382427. Ph. No.: 079-26742739, Fax No. 079-26742740. Email ID: mail@medicointercontinental.com Website: www.medicointercontinental.com RBI UCN NO. :- 897783 V. G'O SWAMI 8 C 0. C&AG REG NO. :- WR4659 'NDpiA CHARTERED ACCOUNTANTS | MfoSrM Eo s:-a aGnJt-i0v1a-o0r1e4r9t6e5s8 B-1006, Titanium Square, Opp.Thaltej Metro, S.G. Highway, Thaltej, Ahmeabad-380059. M : +91 94287 33430, +91 97247 28711 | E-mail : thegoswami@gmail.com | www.goswami.in Independent Auditor’s Review Report on the Quarterly and Year to Date Unaudited Standalone Financial Results of the Company pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015(as amended) TO THE BOARD OF DIRECTORS OF MEDICO INTERCONTINENTAL LIMITED We have reviewed the accompanying Statements of Standalone Unaudited Financial Results of MEDICO INTERCONTINENTAL LIMITED (“the company”), for the quarter ended Septembe30r, 2026 (“the Statement”) and year to date from April 01, 2026 to September 30, 2026 (“the Statement”), being submitted by the Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. This Statement, which is the responsibility of the Company's Management and approved by the Company's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 "Interim Financial Reporting" ("Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013 as amended, read with relevant rules issued thereunder and other accounting principles generally accepted in India. Our responsibility is to express a conclusion on the Statement based on our review. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 'Review of Interim Financial Information performed by the Independent Auditor of the Entity', issued by the Institute of Chartered Accountants of India (ICAI). This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review of interim financial information consists of making inquiries, primarily of the Company's personnel responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying Statement, prepared in accordance with the recognition and measurement principles laid down in the aforesaid Indian Accounting Standard and other accounting principles generally accepted in India, has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, including the manner in which it is to be disclosed, ort hat it contains any material misstatement. For, V. GOSWAMI & €O, Chartered Accountants VIPULBHARTHI (FRN: 0128769W) PRATAPBHART HI GOSWAMI Vipul Goswami (Partner) Mem. No: 119809 Date: - 06/11/2026 Place:-Ahmedabad S e et UDIN: 26119809IPUDPG2652 RBI UCN NO. :- 897783 V. GO SWAMI 8 CO. C&AG REG NO. :- WR4659 'No1A CHARTERED ACCOUNTANTS | McoSrM Es s:-i aGmJi-t0v1s-o0r1e4r9s6a5n8 B-1006, Titanium Square, Opp.Thaltej Metro, S.G. Highway, Thaltej, Ahmeabad-380059. M : +91 94287 33430, +91 97247 28711 | E-mail : thegoswami@gmail.com | www.goswami.in Independent Auditor’s Review Report on the Quarterly and Year to Date Unaudited Consolidated Financial Results of the Company pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) TO THE BOARD OF DIRECTORS OF MEDICO INTERCONTINENTAL LIMITED We have reviewed the accompanying Statements of Consolidated Unaudited Financial Results of MEDICO INTERCONTINENTAL LIMITED (“the Parent”) and its subsidiaries (the Parent and its subsidiaries together referred to as “the Group”), for the quarter ended September 30, 2026 (“the Statement”) and year to date from April 01, 2026 to September 30, 2026 attached herewith, being submitted by the Holding Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. This Statement, which is the responsibility of the Parent’s Management and approved by the Parent's Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in the Indian Accounting Standard 34 "Interim Financial Reporting" ("Ind AS 34"), prescribed under Section 133 of the Companies Act, 2013 read with relevant rules issued thereunder and other accounting principles generally accepted in India. Our responsibility is to express a conclusion on the statement based on our review. We conducted our review of the Statement in accordance with the Standard on Review Engagements (SRE) 2410 'Review of Interim Financial Information performed by the Independent Auditor of the Entity', issued by the Institute of Chartered Accountants of India (ICAl). This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement is free of material misstatement. A review of interim financial information consists of making inquiries, primarily of the Parent Company's personnel responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with Standards on Auditing and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion. We also performed procedures in accordance with the circular issued by the SEBI under Regulation 33(8) of the SEBI (Listing Obligations and Discl [Showing first 8,000 characters — download PDF for full document]